Tag: Gene Editing for RP
CRISPR Therapeutics’ CTX001 for Retinitis Pigmentosa: Targeting and Treating Gene Defects
Retinitis Pigmentosa (RP) is a group of rare, genetic disorders that result in progressive vision loss due to the degeneration of photoreceptor cells in...
